Category: Healthcare

  • Buttock Augmentation Market

    —

    by

    The global buttock augmentation market is projected to witness robust growth, valued at USD 2.4 billion in 2024 and expected to reach USD 27.9 billion by 2034, growing at an impressive CAGR of 28.4% during the forecast period.

  • C-Arms Devices Market

    —

    by

    The global C-Arms devices market is poised to grow significantly, with its valuation projected to increase from USD 2.8 billion in 2024 to USD 3.9 billion by 2034. This growth represents a robust CAGR of 4.6%

  • Calprotectin Testing Market

    —

    by

    The global calprotectin testing market is projected to grow from USD 202.1 billion in 2024 to USD361.2 billion by 2034, exhibiting a CAGR of 7% during the forecast period.

  • Cancer Biopsy Market

    —

    by

    The global cancer biopsy market is projected to experience significant growth over the coming decade.

  • Cancer Diagnostics Market

    —

    by

    The global cancer diagnostics market is projected to witness robust growth, with an estimated valuation of USD 61.4 billion in 2024, expected to surge to USD 137.7 billion by 2034, growing at an accelerated CAGR of 9.5%.

  • Cancer Gene Therapy Market

    —

    by

    In 2026, the cancer gene therapy market size is estimated at USD 2.8 billion, and it is projected to reach USD 8.9 billion by 2033, reflecting a robust CAGR of 17.8% over the forecast period.

  • Cancer Registry Software Market

    —

    by

    The global cancer registry software market is projected to achieve significant growth, with its valuation expected to rise from USD 88.4 million in 2024 to USD 237.0 million by 2034, growing at a robust CAGR of 11.4%.

  • Cancer Tissue Diagnostics Market

    —

    by

    The global cancer tissue diagnostics market is projected to exhibit substantial growth, with its estimated value rising from USD 15,303.2 million in 2024 to USD 23,517.2 million by 2034, reflecting a CAGR of 5.5% during the forecast period.

  • Cancer Vaccines Market 2025-2035

    —

    by

    The global cancer vaccines market is poised for robust growth, with its valuation expected to reach USD 10 billion in 2024 and grow to USD 25.22 billion by 2034, registering a CAGR of 13% over the forecast period.

  • Cancer-Focused Genetic Testing Service Market

    —

    by

    The global cancer-focused genetic testing service market is set to achieve a valuation of USD 9.5 billion in 2024, growing to USD 20.3 billion by 2034, with a compound annual growth rate (CAGR) of 9.6% over the forecast period.